On September 17, the FDA classified an ongoing voluntary recall of chlorthalidone tablets, which are used to treat high blood pressure, as a Class II recall.
On September 17, the FDA classified an ongoing voluntary recall of chlorthalidone tablets, which are used to treat high blood pressure, as a Class II recall.
